Verified Nov 2026
Electronics & Software
·
Seoul, Seoul
·
Since 2000
Seegene Inc. is a biotechnology company headquartered in Seoul, South Korea, founded in 2000. It develops, manufactures, and distributes in vitro molecular diagnostic reagents, instruments, and software for infectious diseases, including multiplex PCR assays for respiratory, sexually transmitted, and gastrointestinal infections. The company employs between 500 and 1,000 people, reported revenue of 327.1M, and is publicly listed on KOSDAQ under ticker 096530. Its customers include research laboratories and clinical diagnostic centers. In December 2025, it established a French subsidiary to expand its European presence.
Seegene Inc. at a glance
Revenue
327.1M
Employees
500-1,000
Founded
2000
Headquarters
Seoul, Seoul
Ownership
Publicly traded (KOE: 096530.KQ)
Certifications
ISO 13485 · ISO 45001
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & strong
26 years in operation (founded 2000).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 45001 certification(s) per public sources.
Overview
Seegene Inc. is a biotechnology company headquartered in Seoul, South Korea, founded in 2000. It develops, manufactures, and distributes in vitro molecular diagnostic reagents, instruments, and software for infectious diseases, including multiplex PCR assays for respiratory, sexually transmitted, and gastrointestinal infections. The company employs between 500 and 1,000 people, reported revenue of 327.1M, and is publicly listed on KOSDAQ under ticker 096530. Its customers include research laboratories and clinical diagnostic centers. In December 2025, it established a French subsidiary to expand its European presence.
At a glance
Attribute | Detail |
|---|---|
Founded | 2000 |
Headquarters | Seoul, Seoul |
Employees | 500-1,000 |
Revenue | 327.1M |
Ownership | Publicly traded (KOE: 096530.KQ) |
Primary capability | Electronics & Software |
Certifications | ISO 13485 · ISO 45001 |
What Seegene Inc. makes
The company holds ISO 13485 and ISO 45001 certifications and offers automated real-time PCR analysis instruments alongside its diagnostic assays and data analysis software.
Certifications
Seegene Inc. is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — seegene.com
ISO 45001 — seegene.com
Latest developments
2026-03-10 — Seegene to Distribute GFE Blood Testing Products | GenomeWeb (genomeweb.com)
2026-02-26 — Seegene returns to profitability in 2025 driven by non-respiratory product growth < Device/ICT < Article - KBR (koreabiomed.com)
2025-12-05 — Seegene Establishes French Subsidiary to Expand European Footprint | Media Center | Seegene (seegene.com)
2025-12-03 — Microbix & Seegene Mexico Collaborate to Improve Test Accuracy - Microbix (microbix.com)
2025-12-02 — Seegene Germany (seegene.de)
2025-08-06 — Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics | Media Center | Seegene (seegene.com)
Company details
Seegene is publicly traded on KOSDAQ and operates subsidiaries in the United States, Canada, Germany, and Brazil, in addition to the newly established French subsidiary. Seegene Inc. was founded in 2000, has an estimated 500-1,000 employees, and is headquartered in Seoul, Seoul. On the LightSource stability read it is rated "Established & strong": 26 years in operation (founded 2000). Publicly listed; no distress event on record. Holds ISO 13485, ISO 45001 certification(s) per public sources.
Frequently asked questions
What does Seegene Inc. make?
Seegene Inc. is a biotechnology company headquartered in Seoul, South Korea, founded in 2000. It develops, manufactures, and distributes in vitro molecular diagnostic reagents, instruments, and software for infectious diseases, including multiplex PCR assays for respiratory, sexually transmitted, and gastrointestinal infections. The company employs between 500 and 1,000 people, reported revenue of 327.1M, and is publicly listed on KOSDAQ under ticker 096530. Its customers include research laboratories and clinical diagnostic centers. In December 2025, it established a French subsidiary to expand its European presence.
Where is Seegene Inc. headquartered?
Seegene Inc. is headquartered in Seoul, Seoul.
When was Seegene Inc. founded?
Seegene Inc. was founded in 2000.
How big is Seegene Inc.?
Seegene Inc. has an estimated 500-1,000 employees, with revenue in the 327.1M range.
Is Seegene Inc. publicly traded?
Publicly traded (KOE: 096530.KQ). Public financial figures are drawn from its filings.
What certifications does Seegene Inc. hold?
Seegene Inc. lists ISO 13485 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.